[1] |
Kweza PF, Van SC, Abraham N, et al. Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa[J]. Int J Tuberc Lung Dis, 2018, 22:264-272.
|
[2] |
Castro-Garza J. Mycobacterium tuberculosis promotes genomic instability in macrophages[J]. Mem Inst Oswaldo Cruz, 2018,113:161-166.
|
[3] |
杜伟勤, 任建斌. γ干扰素,骨桥蛋白,白细胞介素-18在肺结核患者血清与痰液上清液中的表达与临床意义[J]. 中国当代医药, 2010, 27:12-15.
|
[4] |
张文玲, 周学东, 郝玉庆,等. microRNA:一种潜在新型诊断结核病的生物标志物[J]. 四川大学学报:自然科学版, 2015, 52:1399-1403.
|
[5] |
魏文燕, 陈建英. 非编码RNA调控巨噬细胞极化的研究进展[J]. 山东医药,2018, 58:90-94.
|
[6] |
虞秀锋, 王启源, 姬文兰,等. MiR-506-3p/SOCS-3促进BCG感染巨噬细胞引发的炎症应答反应[J]. 中国人兽共患病学报, 2020, 36:297-302.
|
[7] |
Coler RN, Day TA, Ruth E, et al. The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine:first-in-human trial[J]. NPJ Vaccines, 2018,3:34.doi:10.1038/s41541-018-0057-5.
|
[8] |
方志雄, 徐磊, 张海明,等. 肺结核患者血液和痰液中特异性CD4+T淋巴细胞CD27表达水平及其诊断新发肺结核的价值[J]. 广西医学, 2019, 41:3109-3113.
|
[9] |
邓清, 张铁泉, 乐问津,等. 长链非编码RNA DRAIC调控miR-223对胃癌细胞迁移和侵袭的影响[J]. 西部医学, 2018, 30:1753-1757.
|
[10] |
何畏, 陈晴, 黄涛, 等. 肺结核及肺外结核患者外周血T淋巴细胞亚群的变化及其临床意义[J]. 中国防痨杂志, 2019,41:1090-1095.
|
[11] |
蔡灵芝, 何丽波, 林宇航,等. 活动性结核患者结核分枝杆菌抗原特异性多能T淋巴细胞细胞因子的分泌特征[J]. 中华医院感染学杂志, 2019, 29:179-183.
|
[12] |
田杰, 郭淑湘. 活动性肺结核患者痰液及血清中骨桥蛋白,白细胞介素-18和干扰素-γ的检测及意义[J]. 标记免疫分析与临床, 2015, 22:540.
|
[13] |
Roffel MP, Bracke KR, Heijink IH, et al. miR-223:A key regulator in the innate immune response in asthma and COPD[J]. Front Med, 2010, 1:196.doi:10.3389/fmed.2020.00196.
|
[14] |
洪爱玲,朱海燕,何贵清,等.miRNA-223靶向FoxO3抑制肺结核大鼠巨噬细胞凋亡研究[J].浙江医学,2019,41:1610-1613.
|
[15] |
Liu Y,Wang R,Jiang J,et al.miR-223 is upregulated in monocytes from patients with tuberculosis and regulates function of monocyte-derived macrophages[J].Mol Immunol,2015,67:475-481.
|